3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
1
Lymphoma, Follicular
1
Esophageal Squamous Cell Carcinoma
1
Colitis, Ulcerative
1
Interventions
Cisplatin
21
Radiotherapy
16
Fluorouracil
16
Paclitaxel
15
Irinotecan
8
Docetaxel
8
Neoadjuvant Therapy
6
Radiation
5
Drug Therapy
5
toripalimab
4
tislelizumab
4
sintilimab
4
Surgical Procedures, Operative
4
Oxaliplatin
4
Leucovorin
4
Esophagectomy
4
Capecitabine
4
pembrolizumab
3
TP protocol
3
Chemotherapy, Adjuvant
3
S 1 (combination)
2
Levoleucovorin
2
Injections
2
Cetuximab
2
Carboplatin
2
lenvatinib
1
irinotecan sucrosofate
1
durvalumab
1
atropine sulfate-diphenoxylate hydrochloride drug combination
1
atezolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Esophageal Squamous Cell Carcinoma
×
Andrographis paniculata extract
×
Clear all
NCT04196075
2021-11-08
AP
Chinese University of Hong Kong
Phase 3
Completed
30 enrolled